Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - lt toxoid and e. coli antigens, k88ab, k88ac, k99 and 987p - emulsion for injection - porcine - immunological - inactivated vaccine

European Union - English - EMA (European Medicines Agency)

ceva santé animale - genetically modified recombinant shiga-toxin-2e antigen - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - pigs - active immunisation of piglets from the age of four days, to reduce the mortality and clinical signs of oedema disease caused by shiga toxin 2e produced by escherichia coli (stec). onset of immunity: 21 days after vaccination. duration of immunity: 105 days after vaccination.,

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - reduction of neonatal enterotoxicosis of piglets, caused by e. coli strains, expressing the adhesins f4ab, f4ac, f4ad, f5, f6 and f41, during the first days of life.

European Union - English - EMA (European Medicines Agency)

intervet international bv - f4ab (k88ab) fimbrial adhesin, f4ac (k88ac) fimbrial adhesin, f5 (k99) fimbrial adhesin, f6 (987p) fimbrial adhesin, lt toxoid - immunologicals - pigs (gilts and sows) - for the passive immunisation of piglets by active immunisation of sows / gilts to reduce mortality and clinical signs such as diarrhoea due to neonatal enterotoxicosis during the first days of life, caused by those e.coli strains which express the fimbrial adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p).

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - recombinant verotoxin 2e of e. coli - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium, immunologicals for suidae - pigs - active immunisation of piglets from 2 days of age to prevent mortality and reduce clinical signs of oedema disease (caused by verotoxin 2e produced by e. coli) and to reduce the loss of daily weight gain during the finishing period in the face of infections with verotoxin 2e producing e. coli until slaughter from 164 days of age.

European Union - English - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - immunologicals for suidae - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - escherichia coli - suspension for injection - inactivated bacterial vaccine - pigs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

laboratorios hipra sa - genetically modified recombinant stx2e antigen - suspension for injection - inactivated bacterial vaccine - pigs

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kernfarm b.v. - escherichia coli (inactivated) ; escherichia coli (inactivated) ; escherichia coli (inactivated) ; escherichia coli (inactivated) - emulsion for injection - escherichia coli, inactivated - escherichia - pig

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kernfarm b.v. - escherichia coli (inactivated) ; escherichia coli (inactivated) ; escherichia coli (inactivated) ; escherichia coli (inactivated) - emulsion for injection - escherichia